Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Roche Accutane “Fallback” Risk Plan May Test FDA Authority Over Registries
Dec 16 2002
•
By
The Pink Sheet
More from Archive
More from Pink Sheet